SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-094628 from CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362) (CSTL)

CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362)
Date: April 12, 2024 · CIK: 0001447362 · Accession: 0001193125-24-094628

AI Filing Summary & Sentiment

File numbers found in text: 333-277470

Date
April 16, 2024
Author
Not clearly detected
Form
CORRESP
Company
CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362)

Letter

CASTLE BIOSCIENCES, INC.

505 S. Friendswood Drive, Suite 401

Friendswood, Texas 77546

April 12,

Division of Corporation Finance

Office of Trade & Services

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

RE: Castle Biosciences, Inc.

Registration Statement on Form S-3

File No. 333-277470

Ladies and Gentlemen:

Castle Biosciences, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-277470) to become effective on Tuesday, April 16, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157 or, in his absence, Thomas Coll at (858) 550-6013 or Sarah Curry at (212) 479-6652.

[remainder of page intentionally left blank]

Very truly yours,
CASTLE BIOSCIENCES, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 CASTLE BIOSCIENCES, INC.

505 S. Friendswood Drive, Suite 401

Friendswood, Texas 77546

 April 12,
2024

 Division of Corporation Finance

 Office of
Trade & Services

 United States Securities and Exchange Commission

100 F Street, N.E.

 Washington, D.C. 20549

RE:
 Castle Biosciences, Inc.

Registration Statement on Form S-3

File No. 333-277470

Ladies and Gentlemen:

 Castle Biosciences, Inc.
(the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-277470) to become effective on Tuesday, April 16, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time
as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to
the Registrant, at (858) 550-6157 or, in his absence, Thomas Coll at (858) 550-6013 or Sarah Curry at (212) 479-6652.

[remainder of page intentionally left blank]

Very truly yours,

CASTLE BIOSCIENCES, INC.

By:

/s/ Derek J. Maetzold

Name:

Derek J. Maetzold

Title:

President and Chief Executive Officer

cc:
 Carlos Ramirez, Cooley LLP

Thomas Coll, Cooley LLP

 Sarah
Curry, Cooley LLP